- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07639853
Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils
The purpose of the Case-Specific Health Care Professional (HCP) Clinical Survey for Concerto Versa™ Detachable Coils, also known as the Concerto Versa HCP Clinical Assessment, is to collect early clinical data from HCPs to assess clinical safety and performance of the Concerto Versa™ Detachable Coils, when used in accordance with approved device labeling per the Instructions for Use (IFU). Data collected will generate clinical evidence to quantitatively assess clinical safety and device performance for the purpose of obtaining European Union Medical Device Regulation (EU MDR) approval.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The Concerto Versa™ Health Care Professional (HCP) Clinical Assessment is a multicenter, prospective per patient HCP recollection survey. Participating HCPs will document their individual use case experience following routine utilization of Concerto Versa™ in accordance with the approved device labeling. Individual use cases will be entered within 72 hours of device usage to identify periprocedural safety incidents and evaluate device performance. At least 30 use cases will be collected and aggregated from participating HCPs. This data collection is a for a single point in time, with no patient follow-up. Individual HCP responses for each case will be aggregated by a third party vendor.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiesteder
-
-
New Jersey
-
Piscataway, New Jersey, Forenede Stater, 08854
- Rutgers University
-
-
New York
-
New York, New York, Forenede Stater, 10029
- The Mount Sinai Hospital
-
-
Texas
-
El Paso, Texas, Forenede Stater, 79925
- Del Sol Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
The Concerto Versa™ Detachable Coil is indicated for arterial and venous embolization in adult patients requiring embolization in the peripheral vasculature.
Beskrivelse
Inclusion Criteria:
- Patient treated with Concerto Versa™ Detachable Coil is age ≥ 22 years at the time of procedure.
- Use of Concerto Versa™ Detachable Coil in accordance with the device labeling.
- Reporting of case within 72 hours of index procedure.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Adult patients treated with Concerto Versa™ Detachable Coil
The Concerto Versa™ Detachable Coil is indicated for arterial and venous embolization in adult patients requiring embolization in the peripheral vasculature. |
Concerto Versa™ detachable coil is indicated for arterial and venous embolization in the peripheral vasculature |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of peri-procedural adverse events
Tidsramme: During the Index Procedure
|
The rate of peri-procedural adverse events related to device and/or procedure. |
During the Index Procedure
|
|
Rate of Technical Success
Tidsramme: During the Index Procedure
|
Technical success is defined as successful delivery and detachment of the coil, and removal of the delivery-pusher. |
During the Index Procedure
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of Peri-procedural success
Tidsramme: During the Index Procedure
|
Peri-procedural success is defined as ability of the device to successfully obstruct or reduce the rate of blood flow to the target lesion as determined by physician judgment. |
During the Index Procedure
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: John R Laird, Jr, MD, Medtronic Endovascular
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Genitale sygdomme
- Hjerte-kar-sygdomme
- Patologiske processer
- Kønssygdomme, mandlige
- Mandlige urogenitale sygdomme
- Tarmsygdomme
- Sygdomme i fordøjelsessystemet
- Gastrointestinale sygdomme
- Endetarmssygdomme
- Leversygdomme
- Esophageale sygdomme
- Medfødte abnormiteter
- Kardiovaskulære abnormiteter
- Åreforkalkning
- Åreforkalkning
- Arterielle okklusive sygdomme
- Vaskulære misdannelser
- Hypertension, Portal
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Karsygdomme
- Perifer arteriel sygdom
- Blødning
- Perifere vaskulære sygdomme
- Gastrointestinal blødning
- Hæmorider
- Arteriovenøse misdannelser
- Spiserør og mavevaricer
- Varicocele
Andre undersøgelses-id-numre
- MDT25037
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
No patients will be engaged, and no medical records will be accessed or used. Individual HCP responses for each case will be aggregated into a final report.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .